Utilizing adoptive transfer, flow cytometry, qPCR, imaging, lipidomics, and ex-vivo approaches, we find that CD4+ and CD8+ T cells with reduced iPLA2β exhibit a mitigated inflammatory landscape and are less effective in inducing T1D. Here, CD4 is linked to type 1 diabetes mellitus.